By identifying promising discoveries and advancing their translation, CCRM has enabled and supported new companies. As of September 2024, we have co-founded one company, incubated a second, and supported the launch of 16 more (18 total) that together have raised more than CA $1.2B.

Portfolio Companies

IC-fullmember_0000s_0024_aspect
Endogena Therapeutics
External link to ExCellThera
Feldan Therapeutics
Intelligent Vector Solutions - iVexSol logo
Kisoji Biotechnology
LineaBio logo
Mesentech
Morophocell Technologies
Notch Therapeutics

Past Exits

Learn more on our Investing Strategy and Funding and Strategic Support pages.